Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Scientific Reports|August 3, 2025
Pilot study of cerebrospinal fluid biomarkers reveals inflammatory changes in patients with paranoid schizophreniaFranz Felix Konen, Philipp Sebastian Gehring, Hannah Benedictine Maier, et al.
Scientific Reports|March 28, 2024
Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017Konstantin F Jendretzky, Anna Bajor, Lisa-Marie Lezius, et al.
Psychiatry Research|January 14, 2024
The significance of cerebrospinal fluid analysis in the differential diagnosis of 564 psychiatric patients: Multiple sclerosis is more common than autoimmune-encephalitisHannah Benedictine Maier, Jan Stadler, Stephanie Deest-Gaubatz, et al.
Neurological Research and Practice|August 23, 2025
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumabFranz Felix Konen, Gudrun Mechthild Körner, Martin W Hümmert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
CSF Beta-Synuclein, SNAP-25, and Neurogranin in Infectious and Autoimmune Inflammatory Neurologic DiseasesSamir Abu-Rumeileh, Deborah K Erhart, Lorenzo Barba, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 4, 2025
Switching from anti-CD20 therapies to cladribine and vice versa - Analysis of a German relapsing multiple sclerosis cohortFranz Felix Konen, Steffen Pfeuffer, Konstantin Fritz Jendretzky, et al.
Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.
Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2025
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosisPia Winter, Franziska Axhausen, Stephanie Wolff, et al.
Neurological Research and Practice|November 13, 2024
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patientsKonstantin Fritz Jendretzky, Lisa-Marie Lezius, Thea Thiele, et al.
Pageof 6